1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole | CAS:73963-42-5

We serve 1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole CAS:73963-42-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole

Chemical Name:1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole
CAS.NO:73963-42-5
Synonyms:1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole
5-(4-Chlorobutyl)-1-cyclohexanyl tetrazole
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 425.2±24.0 °C at 760 mmHg
Melting Point 49-52°C
Molecular Formula C11H19ClN4
Molecular Weight 242.748
Flash Point 210.9±22.9 °C
 
Specification:
Appearance:White to off-white powder
Assay:≥99.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Cilostazol(CAS:73963-72-1).



Contact us for information like 1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(4-Chlorobutyl)-1-cyclohexanyl tetrazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole Use and application,5-(4-Chlorobutyl)-1-cyclohexanyl tetrazole technical grade,usp/ep/jp grade.


Related News: In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate manufacturer The Philippines reported its first Wuhan coronavirus fatality on Sunday.DL-Norvaline supplier Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities.γ-Butyrolactone vendor GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”Such was the apparent demand sparked by the notice that the compound formula sold out on some stores on China’s e-commerce platform Taobao.